Respiro Health is building India's first patient-initiated respiratory health screening platform — a pull model where anyone with WhatsApp can screen themselves, without a health worker, without an app download, without leaving home.
From TB to COPD to asthma — India's respiratory disease burden is massive, largely undetected, and concentrated in populations that don't reach a doctor in time. Most respiratory diseases go undetected because people don't seek care in time — due to normalising symptoms, stigma, distance, or not knowing their cough is serious. By the time they reach a doctor, the disease has progressed. The gap is pre-diagnostic, and it is enormous.
Existing AI screening tools use a push model — a trained health worker goes out to find the patient. Respiro is a pull model — the patient initiates screening themselves, privately, before they've decided to visit a clinic.
No app download. No registration. Works on any phone that already has WhatsApp — 500 million in India.
A 30-second guided voice note, in the patient's own language. Private. No health worker present.
Respiratory patterns combined with symptom inputs are processed by our AI pipeline. A risk assessment is generated in seconds.
High-risk patients are guided to the nearest appropriate healthcare facility. The system routes people toward care — not around it.
We are building a clinically rigorous respiratory dataset — recordings linked to confirmed diagnoses from hospitals and clinics across India. Starting with high-burden infectious respiratory disease and expanding to chronic conditions — our dataset covers the full spectrum of respiratory health.
Working with private pulmonologists across India to capture confirmed asthma, COPD, and bronchitis cases — linked to spirometry and clinical diagnosis.
Our coordinator captures patient history before the consultation begins. Doctor receives a structured summary. Better information in less time — for both patient and physician.
Active academic research collaborations with medical institutions for rigorous clinical validation of our screening approach across respiratory conditions.
Respiro is a technical founder-led company with clinical advisory from some of India's leading respiratory health and public health experts.
We are building Respiro with partners who understand the clinical reality of respiratory health in India — from private pulmonologists to hospital administrators to public health implementers. If your work touches respiratory health, we want to talk.
Private pulmonology clinics, chest OPDs, and hospitals interested in improving pre-consultation workflow and participating in our clinical data partnership programme.
Medical colleges and research institutions interested in co-authorship and joint grant applications for respiratory health AI research.
Government health institutions and public health implementation organisations working on respiratory disease elimination programmes across India.
Investors who understand the Indian healthcare market and bring clinical or government relationships alongside capital. We are raising our seed round.
Whether you run a clinic, lead a hospital department, work in public health, or invest in health-tech — we want to hear from you.